nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GRIN2A—epilepsy syndrome	0.267	1	CbGaD
Glycine—SLC36A1—Vigabatrin—epilepsy syndrome	0.243	0.646	CbGbCtD
Glycine—GRIN2A—Felbamate—epilepsy syndrome	0.133	0.354	CbGbCtD
Glycine—GARS—telencephalic ventricle—epilepsy syndrome	0.00221	0.0261	CbGeAlD
Glycine—Aminolevulinic acid—ALAD—epilepsy syndrome	0.00209	0.546	CrCbGaD
Glycine—SLC6A5—brainstem—epilepsy syndrome	0.00162	0.0191	CbGeAlD
Glycine—GLRA2—hindbrain—epilepsy syndrome	0.00148	0.0175	CbGeAlD
Glycine—GCAT—hindbrain—epilepsy syndrome	0.00131	0.0154	CbGeAlD
Glycine—SLC32A1—forebrain—epilepsy syndrome	0.00122	0.0145	CbGeAlD
Glycine—Aminocaproic Acid—PLAT—epilepsy syndrome	0.00122	0.318	CrCbGaD
Glycine—SLC32A1—telencephalon—epilepsy syndrome	0.00113	0.0133	CbGeAlD
Glycine—GARS—hindbrain—epilepsy syndrome	0.00104	0.0123	CbGeAlD
Glycine—GRIN2C—hindbrain—epilepsy syndrome	0.00103	0.0121	CbGeAlD
Glycine—SLC6A5—spinal cord—epilepsy syndrome	0.00101	0.0119	CbGeAlD
Glycine—GATM—hindbrain—epilepsy syndrome	0.000991	0.0117	CbGeAlD
Glycine—GCSH—forebrain—epilepsy syndrome	0.000964	0.0114	CbGeAlD
Glycine—GRIN2A—ganglion—epilepsy syndrome	0.000936	0.0111	CbGeAlD
Glycine—SLC6A5—head—epilepsy syndrome	0.000893	0.0106	CbGeAlD
Glycine—SLC32A1—medulla oblongata—epilepsy syndrome	0.000885	0.0104	CbGeAlD
Glycine—SLC6A9—medulla oblongata—epilepsy syndrome	0.000854	0.0101	CbGeAlD
Glycine—GLRA2—brainstem—epilepsy syndrome	0.000849	0.01	CbGeAlD
Glycine—SLC6A5—nervous system—epilepsy syndrome	0.000847	0.01	CbGeAlD
Glycine—GSS—ganglion—epilepsy syndrome	0.000819	0.00967	CbGeAlD
Glycine—SLC6A5—central nervous system—epilepsy syndrome	0.000815	0.00963	CbGeAlD
Glycine—SLC32A1—spinal cord—epilepsy syndrome	0.000789	0.00932	CbGeAlD
Glycine—SLC6A9—midbrain—epilepsy syndrome	0.000781	0.00922	CbGeAlD
Glycine—SLC6A9—spinal cord—epilepsy syndrome	0.000762	0.009	CbGeAlD
Glycine—GLYATL2—head—epilepsy syndrome	0.00076	0.00897	CbGeAlD
Glycine—GCAT—brainstem—epilepsy syndrome	0.000749	0.00885	CbGeAlD
Glycine—GLDC—telencephalon—epilepsy syndrome	0.000734	0.00868	CbGeAlD
Glycine—GLYATL2—nervous system—epilepsy syndrome	0.00072	0.00851	CbGeAlD
Glycine—GRIN2A—hindbrain—epilepsy syndrome	0.00071	0.00838	CbGeAlD
Glycine—SLC36A1—hindbrain—epilepsy syndrome	0.000705	0.00833	CbGeAlD
Glycine—SLC32A1—head—epilepsy syndrome	0.000701	0.00828	CbGeAlD
Glycine—GLYATL2—central nervous system—epilepsy syndrome	0.000693	0.00819	CbGeAlD
Glycine—PIPOX—telencephalon—epilepsy syndrome	0.000686	0.0081	CbGeAlD
Glycine—SLC6A9—head—epilepsy syndrome	0.000677	0.008	CbGeAlD
Glycine—GLRA3—head—epilepsy syndrome	0.000677	0.008	CbGeAlD
Glycine—SLC32A1—nervous system—epilepsy syndrome	0.000665	0.00785	CbGeAlD
Glycine—SLC6A5—brain—epilepsy syndrome	0.000647	0.00765	CbGeAlD
Glycine—SLC6A9—nervous system—epilepsy syndrome	0.000642	0.00758	CbGeAlD
Glycine—GLRA3—nervous system—epilepsy syndrome	0.000642	0.00758	CbGeAlD
Glycine—SLC32A1—central nervous system—epilepsy syndrome	0.00064	0.00756	CbGeAlD
Glycine—ALAS1—forebrain—epilepsy syndrome	0.000634	0.00749	CbGeAlD
Glycine—SLC32A1—cerebellum—epilepsy syndrome	0.000625	0.00739	CbGeAlD
Glycine—GLRA3—central nervous system—epilepsy syndrome	0.000618	0.0073	CbGeAlD
Glycine—SLC6A9—central nervous system—epilepsy syndrome	0.000618	0.0073	CbGeAlD
Glycine—GARS—brainstem—epilepsy syndrome	0.000598	0.00707	CbGeAlD
Glycine—GRIN2C—brainstem—epilepsy syndrome	0.000589	0.00695	CbGeAlD
Glycine—ALAS1—telencephalon—epilepsy syndrome	0.000583	0.00689	CbGeAlD
Glycine—GARS—forebrain—epilepsy syndrome	0.000577	0.00682	CbGeAlD
Glycine—GLDC—medulla oblongata—epilepsy syndrome	0.000577	0.00682	CbGeAlD
Glycine—GRIN2C—forebrain—epilepsy syndrome	0.000568	0.00671	CbGeAlD
Glycine—GATM—brainstem—epilepsy syndrome	0.000568	0.00671	CbGeAlD
Glycine—GCSH—head—epilepsy syndrome	0.000552	0.00652	CbGeAlD
Glycine—GLYATL2—brain—epilepsy syndrome	0.00055	0.0065	CbGeAlD
Glycine—GATM—forebrain—epilepsy syndrome	0.000548	0.00648	CbGeAlD
Glycine—GLRA1—nervous system—epilepsy syndrome	0.000546	0.00645	CbGeAlD
Glycine—PIPOX—medulla oblongata—epilepsy syndrome	0.000539	0.00636	CbGeAlD
Glycine—GARS—telencephalon—epilepsy syndrome	0.000531	0.00627	CbGeAlD
Glycine—GLDC—midbrain—epilepsy syndrome	0.000527	0.00623	CbGeAlD
Glycine—GLRA1—central nervous system—epilepsy syndrome	0.000525	0.00621	CbGeAlD
Glycine—GCSH—nervous system—epilepsy syndrome	0.000523	0.00618	CbGeAlD
Glycine—GCAT—medulla oblongata—epilepsy syndrome	0.000523	0.00617	CbGeAlD
Glycine—GRIN2C—telencephalon—epilepsy syndrome	0.000522	0.00617	CbGeAlD
Glycine—L-Alanine—ABAT—epilepsy syndrome	0.000519	0.136	CrCbGaD
Glycine—GLDC—spinal cord—epilepsy syndrome	0.000515	0.00608	CbGeAlD
Glycine—AGXT—cerebellum—epilepsy syndrome	0.000514	0.00607	CbGeAlD
Glycine—SLC32A1—brain—epilepsy syndrome	0.000508	0.006	CbGeAlD
Glycine—GATM—telencephalon—epilepsy syndrome	0.000504	0.00595	CbGeAlD
Glycine—GCSH—central nervous system—epilepsy syndrome	0.000504	0.00595	CbGeAlD
Glycine—GCSH—cerebellum—epilepsy syndrome	0.000492	0.00582	CbGeAlD
Glycine—PIPOX—midbrain—epilepsy syndrome	0.000492	0.00582	CbGeAlD
Glycine—GLRA3—brain—epilepsy syndrome	0.000491	0.0058	CbGeAlD
Glycine—SLC6A9—brain—epilepsy syndrome	0.000491	0.0058	CbGeAlD
Glycine—PIPOX—spinal cord—epilepsy syndrome	0.00048	0.00568	CbGeAlD
Glycine—GCAT—midbrain—epilepsy syndrome	0.000478	0.00564	CbGeAlD
Glycine—GLRB—forebrain—epilepsy syndrome	0.000471	0.00556	CbGeAlD
Glycine—GLRA2—head—epilepsy syndrome	0.000469	0.00554	CbGeAlD
Glycine—GCAT—spinal cord—epilepsy syndrome	0.000466	0.00551	CbGeAlD
Glycine—SHMT2—telencephalon—epilepsy syndrome	0.000462	0.00546	CbGeAlD
Glycine—ALAS1—medulla oblongata—epilepsy syndrome	0.000458	0.00541	CbGeAlD
Glycine—GLDC—head—epilepsy syndrome	0.000457	0.0054	CbGeAlD
Glycine—GLRA2—nervous system—epilepsy syndrome	0.000445	0.00526	CbGeAlD
Glycine—GLDC—nervous system—epilepsy syndrome	0.000434	0.00512	CbGeAlD
Glycine—GLRB—telencephalon—epilepsy syndrome	0.000433	0.00511	CbGeAlD
Glycine—GLRA2—central nervous system—epilepsy syndrome	0.000428	0.00506	CbGeAlD
Glycine—PIPOX—head—epilepsy syndrome	0.000427	0.00504	CbGeAlD
Glycine—GLRA2—cerebellum—epilepsy syndrome	0.000419	0.00495	CbGeAlD
Glycine—ALAS1—midbrain—epilepsy syndrome	0.000419	0.00495	CbGeAlD
Glycine—GLDC—central nervous system—epilepsy syndrome	0.000417	0.00493	CbGeAlD
Glycine—GARS—medulla oblongata—epilepsy syndrome	0.000417	0.00493	CbGeAlD
Glycine—GCAT—head—epilepsy syndrome	0.000414	0.00489	CbGeAlD
Glycine—GRIN2C—medulla oblongata—epilepsy syndrome	0.00041	0.00485	CbGeAlD
Glycine—ALAS1—spinal cord—epilepsy syndrome	0.000408	0.00483	CbGeAlD
Glycine—GLDC—cerebellum—epilepsy syndrome	0.000408	0.00482	CbGeAlD
Glycine—GRIN2A—brainstem—epilepsy syndrome	0.000407	0.0048	CbGeAlD
Glycine—PIPOX—nervous system—epilepsy syndrome	0.000405	0.00478	CbGeAlD
Glycine—SLC36A1—brainstem—epilepsy syndrome	0.000404	0.00477	CbGeAlD
Glycine—GCSH—brain—epilepsy syndrome	0.0004	0.00473	CbGeAlD
Glycine—GCAT—nervous system—epilepsy syndrome	0.000393	0.00464	CbGeAlD
Glycine—GRIN2A—forebrain—epilepsy syndrome	0.000392	0.00464	CbGeAlD
Glycine—PIPOX—central nervous system—epilepsy syndrome	0.00039	0.0046	CbGeAlD
Glycine—GARS—midbrain—epilepsy syndrome	0.000381	0.0045	CbGeAlD
Glycine—PIPOX—cerebellum—epilepsy syndrome	0.000381	0.0045	CbGeAlD
Glycine—GCAT—central nervous system—epilepsy syndrome	0.000378	0.00447	CbGeAlD
Glycine—GARS—spinal cord—epilepsy syndrome	0.000372	0.0044	CbGeAlD
Glycine—GCAT—cerebellum—epilepsy syndrome	0.000369	0.00437	CbGeAlD
Glycine—ALAS1—head—epilepsy syndrome	0.000363	0.00429	CbGeAlD
Glycine—GATM—midbrain—epilepsy syndrome	0.000362	0.00428	CbGeAlD
Glycine—GRIN2A—telencephalon—epilepsy syndrome	0.000361	0.00426	CbGeAlD
Glycine—SLC36A1—telencephalon—epilepsy syndrome	0.000359	0.00424	CbGeAlD
Glycine—GSS—brainstem—epilepsy syndrome	0.000356	0.0042	CbGeAlD
Glycine—GATM—spinal cord—epilepsy syndrome	0.000353	0.00417	CbGeAlD
Glycine—GNMT—brain—epilepsy syndrome	0.00035	0.00413	CbGeAlD
Glycine—ALAS1—nervous system—epilepsy syndrome	0.000344	0.00407	CbGeAlD
Glycine—GSS—forebrain—epilepsy syndrome	0.000343	0.00406	CbGeAlD
Glycine—GLRB—medulla oblongata—epilepsy syndrome	0.00034	0.00402	CbGeAlD
Glycine—GLRA2—brain—epilepsy syndrome	0.00034	0.00402	CbGeAlD
Glycine—SHMT2—midbrain—epilepsy syndrome	0.000332	0.00392	CbGeAlD
Glycine—GLDC—brain—epilepsy syndrome	0.000331	0.00392	CbGeAlD
Glycine—ALAS1—central nervous system—epilepsy syndrome	0.000331	0.00391	CbGeAlD
Glycine—GARS—head—epilepsy syndrome	0.000331	0.00391	CbGeAlD
Glycine—GRIN2C—head—epilepsy syndrome	0.000325	0.00384	CbGeAlD
Glycine—ALAS1—cerebellum—epilepsy syndrome	0.000324	0.00383	CbGeAlD
Glycine—GSS—telencephalon—epilepsy syndrome	0.000316	0.00373	CbGeAlD
Glycine—GATM—head—epilepsy syndrome	0.000314	0.00371	CbGeAlD
Glycine—GARS—nervous system—epilepsy syndrome	0.000313	0.0037	CbGeAlD
Glycine—GLRB—midbrain—epilepsy syndrome	0.000311	0.00367	CbGeAlD
Glycine—PIPOX—brain—epilepsy syndrome	0.000309	0.00366	CbGeAlD
Glycine—GRIN2C—nervous system—epilepsy syndrome	0.000308	0.00364	CbGeAlD
Glycine—GLRB—spinal cord—epilepsy syndrome	0.000303	0.00358	CbGeAlD
Glycine—GARS—central nervous system—epilepsy syndrome	0.000302	0.00357	CbGeAlD
Glycine—GCAT—brain—epilepsy syndrome	0.0003	0.00355	CbGeAlD
Glycine—GATM—nervous system—epilepsy syndrome	0.000298	0.00352	CbGeAlD
Glycine—GRIN2C—central nervous system—epilepsy syndrome	0.000297	0.00351	CbGeAlD
Glycine—GARS—cerebellum—epilepsy syndrome	0.000295	0.00348	CbGeAlD
Glycine—GRIN2C—cerebellum—epilepsy syndrome	0.00029	0.00343	CbGeAlD
Glycine—SHMT2—head—epilepsy syndrome	0.000288	0.0034	CbGeAlD
Glycine—GATM—central nervous system—epilepsy syndrome	0.000286	0.00338	CbGeAlD
Glycine—GRIN2A—medulla oblongata—epilepsy syndrome	0.000284	0.00335	CbGeAlD
Glycine—GATM—cerebellum—epilepsy syndrome	0.00028	0.00331	CbGeAlD
Glycine—SHMT2—nervous system—epilepsy syndrome	0.000273	0.00322	CbGeAlD
Glycine—GLRB—head—epilepsy syndrome	0.00027	0.00318	CbGeAlD
Glycine—ALAS1—brain—epilepsy syndrome	0.000263	0.00311	CbGeAlD
Glycine—SHMT2—central nervous system—epilepsy syndrome	0.000263	0.0031	CbGeAlD
Glycine—SHMT1—head—epilepsy syndrome	0.000262	0.00309	CbGeAlD
Glycine—GRIN2A—midbrain—epilepsy syndrome	0.000259	0.00306	CbGeAlD
Glycine—SHMT2—cerebellum—epilepsy syndrome	0.000257	0.00303	CbGeAlD
Glycine—GLRB—nervous system—epilepsy syndrome	0.000256	0.00302	CbGeAlD
Glycine—GRIN2A—spinal cord—epilepsy syndrome	0.000253	0.00299	CbGeAlD
Glycine—SHMT1—nervous system—epilepsy syndrome	0.000248	0.00293	CbGeAlD
Glycine—GSS—medulla oblongata—epilepsy syndrome	0.000248	0.00293	CbGeAlD
Glycine—GLRB—central nervous system—epilepsy syndrome	0.000246	0.00291	CbGeAlD
Glycine—GLRB—cerebellum—epilepsy syndrome	0.00024	0.00284	CbGeAlD
Glycine—GARS—brain—epilepsy syndrome	0.00024	0.00283	CbGeAlD
Glycine—SHMT1—central nervous system—epilepsy syndrome	0.000239	0.00282	CbGeAlD
Glycine—GRIN2C—brain—epilepsy syndrome	0.000236	0.00278	CbGeAlD
Glycine—SHMT1—cerebellum—epilepsy syndrome	0.000234	0.00276	CbGeAlD
Glycine—GATM—brain—epilepsy syndrome	0.000227	0.00269	CbGeAlD
Glycine—GSS—midbrain—epilepsy syndrome	0.000227	0.00268	CbGeAlD
Glycine—GRIN2A—head—epilepsy syndrome	0.000225	0.00266	CbGeAlD
Glycine—SLC36A1—head—epilepsy syndrome	0.000223	0.00264	CbGeAlD
Glycine—GSS—spinal cord—epilepsy syndrome	0.000221	0.00261	CbGeAlD
Glycine—GRIN2A—nervous system—epilepsy syndrome	0.000213	0.00252	CbGeAlD
Glycine—SLC36A1—nervous system—epilepsy syndrome	0.000212	0.0025	CbGeAlD
Glycine—Chills—Clonazepam—epilepsy syndrome	0.000209	0.00179	CcSEcCtD
Glycine—Nausea—Primidone—epilepsy syndrome	0.000209	0.00179	CcSEcCtD
Glycine—SHMT2—brain—epilepsy syndrome	0.000208	0.00246	CbGeAlD
Glycine—Vertigo—Fosphenytoin—epilepsy syndrome	0.000208	0.00178	CcSEcCtD
Glycine—Convulsion—Levetiracetam—epilepsy syndrome	0.000208	0.00178	CcSEcCtD
Glycine—Chills—Phenytoin—epilepsy syndrome	0.000208	0.00178	CcSEcCtD
Glycine—Chills—Oxcarbazepine—epilepsy syndrome	0.000207	0.00177	CcSEcCtD
Glycine—Dehydration—Pregabalin—epilepsy syndrome	0.000206	0.00177	CcSEcCtD
Glycine—GRIN2A—central nervous system—epilepsy syndrome	0.000205	0.00242	CbGeAlD
Glycine—Hyponatraemia—Gabapentin—epilepsy syndrome	0.000204	0.00175	CcSEcCtD
Glycine—SLC36A1—central nervous system—epilepsy syndrome	0.000204	0.00241	CbGeAlD
Glycine—Vertigo—Vigabatrin—epilepsy syndrome	0.000203	0.00174	CcSEcCtD
Glycine—Oedema—Propofol—epilepsy syndrome	0.000203	0.00174	CcSEcCtD
Glycine—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000202	0.00173	CcSEcCtD
Glycine—Convulsion—Fosphenytoin—epilepsy syndrome	0.000201	0.00172	CcSEcCtD
Glycine—GRIN2A—cerebellum—epilepsy syndrome	0.000201	0.00237	CbGeAlD
Glycine—Urticaria—Lacosamide—epilepsy syndrome	0.0002	0.00172	CcSEcCtD
Glycine—Vertigo—Diazepam—epilepsy syndrome	0.0002	0.00171	CcSEcCtD
Glycine—SLC36A1—cerebellum—epilepsy syndrome	0.000199	0.00235	CbGeAlD
Glycine—Chills—Carbamazepine—epilepsy syndrome	0.000198	0.0017	CcSEcCtD
Glycine—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000198	0.00169	CcSEcCtD
Glycine—Tachycardia—Propofol—epilepsy syndrome	0.000198	0.00169	CcSEcCtD
Glycine—GSS—head—epilepsy syndrome	0.000197	0.00232	CbGeAlD
Glycine—Vomiting—Trimethadione—epilepsy syndrome	0.000197	0.00168	CcSEcCtD
Glycine—Back pain—Clonazepam—epilepsy syndrome	0.000196	0.00168	CcSEcCtD
Glycine—Convulsion—Vigabatrin—epilepsy syndrome	0.000196	0.00167	CcSEcCtD
Glycine—GLRB—brain—epilepsy syndrome	0.000195	0.00231	CbGeAlD
Glycine—Back pain—Phenytoin—epilepsy syndrome	0.000195	0.00167	CcSEcCtD
Glycine—Polyuria—Topiramate—epilepsy syndrome	0.000195	0.00167	CcSEcCtD
Glycine—Urticaria—Clobazam—epilepsy syndrome	0.000195	0.00167	CcSEcCtD
Glycine—Back pain—Oxcarbazepine—epilepsy syndrome	0.000194	0.00166	CcSEcCtD
Glycine—Tachycardia—Midazolam—epilepsy syndrome	0.000194	0.00166	CcSEcCtD
Glycine—Urinary retention—Gabapentin—epilepsy syndrome	0.000193	0.00166	CcSEcCtD
Glycine—Chills—Lamotrigine—epilepsy syndrome	0.000192	0.00164	CcSEcCtD
Glycine—Vision blurred—Clonazepam—epilepsy syndrome	0.000191	0.00164	CcSEcCtD
Glycine—SHMT1—brain—epilepsy syndrome	0.00019	0.00224	CbGeAlD
Glycine—Hypotension—Propofol—epilepsy syndrome	0.000189	0.00162	CcSEcCtD
Glycine—Vertigo—Zonisamide—epilepsy syndrome	0.000189	0.00162	CcSEcCtD
Glycine—Dehydration—Gabapentin—epilepsy syndrome	0.000189	0.00162	CcSEcCtD
Glycine—Vision blurred—Oxcarbazepine—epilepsy syndrome	0.000189	0.00162	CcSEcCtD
Glycine—Angina pectoris—Pregabalin—epilepsy syndrome	0.000187	0.0016	CcSEcCtD
Glycine—GSS—nervous system—epilepsy syndrome	0.000186	0.0022	CbGeAlD
Glycine—Back pain—Carbamazepine—epilepsy syndrome	0.000186	0.00159	CcSEcCtD
Glycine—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000186	0.00159	CcSEcCtD
Glycine—Hypotension—Midazolam—epilepsy syndrome	0.000185	0.00159	CcSEcCtD
Glycine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000184	0.00158	CcSEcCtD
Glycine—Oedema—Vigabatrin—epilepsy syndrome	0.000184	0.00158	CcSEcCtD
Glycine—Diarrhoea—Rufinamide—epilepsy syndrome	0.000184	0.00157	CcSEcCtD
Glycine—Nausea—Trimethadione—epilepsy syndrome	0.000184	0.00157	CcSEcCtD
Glycine—Convulsion—Zonisamide—epilepsy syndrome	0.000182	0.00156	CcSEcCtD
Glycine—Vertigo—Clonazepam—epilepsy syndrome	0.000182	0.00156	CcSEcCtD
Glycine—Vision blurred—Carbamazepine—epilepsy syndrome	0.000181	0.00155	CcSEcCtD
Glycine—Vertigo—Phenytoin—epilepsy syndrome	0.000181	0.00155	CcSEcCtD
Glycine—Dizziness—Phenobarbital—epilepsy syndrome	0.000181	0.00155	CcSEcCtD
Glycine—Visual disturbance—Topiramate—epilepsy syndrome	0.000181	0.00155	CcSEcCtD
Glycine—Vertigo—Oxcarbazepine—epilepsy syndrome	0.00018	0.00154	CcSEcCtD
Glycine—Back pain—Lamotrigine—epilepsy syndrome	0.00018	0.00154	CcSEcCtD
Glycine—Thirst—Topiramate—epilepsy syndrome	0.00018	0.00154	CcSEcCtD
Glycine—GSS—central nervous system—epilepsy syndrome	0.000179	0.00212	CbGeAlD
Glycine—Dizziness—Rufinamide—epilepsy syndrome	0.000178	0.00152	CcSEcCtD
Glycine—Tachycardia—Diazepam—epilepsy syndrome	0.000177	0.00152	CcSEcCtD
Glycine—Hypotension—Fosphenytoin—epilepsy syndrome	0.000177	0.00151	CcSEcCtD
Glycine—Oedema—Felbamate—epilepsy syndrome	0.000176	0.0015	CcSEcCtD
Glycine—GSS—cerebellum—epilepsy syndrome	0.000175	0.00207	CbGeAlD
Glycine—Vision blurred—Lamotrigine—epilepsy syndrome	0.000175	0.0015	CcSEcCtD
Glycine—Convulsion—Phenytoin—epilepsy syndrome	0.000175	0.0015	CcSEcCtD
Glycine—Vomiting—Phenobarbital—epilepsy syndrome	0.000174	0.00149	CcSEcCtD
Glycine—Convulsion—Oxcarbazepine—epilepsy syndrome	0.000174	0.00149	CcSEcCtD
Glycine—Urticaria—Acetazolamide—epilepsy syndrome	0.000173	0.00148	CcSEcCtD
Glycine—Pain—Propofol—epilepsy syndrome	0.000173	0.00148	CcSEcCtD
Glycine—Vertigo—Carbamazepine—epilepsy syndrome	0.000173	0.00148	CcSEcCtD
Glycine—Diarrhoea—Lacosamide—epilepsy syndrome	0.000173	0.00148	CcSEcCtD
Glycine—Oedema—Zonisamide—epilepsy syndrome	0.000172	0.00147	CcSEcCtD
Glycine—Hyponatraemia—Topiramate—epilepsy syndrome	0.000172	0.00147	CcSEcCtD
Glycine—Tachycardia—Felbamate—epilepsy syndrome	0.000171	0.00147	CcSEcCtD
Glycine—Angina pectoris—Gabapentin—epilepsy syndrome	0.000171	0.00147	CcSEcCtD
Glycine—Vomiting—Rufinamide—epilepsy syndrome	0.000171	0.00146	CcSEcCtD
Glycine—Rhinitis—Valproic Acid—epilepsy syndrome	0.00017	0.00146	CcSEcCtD
Glycine—Pain—Midazolam—epilepsy syndrome	0.00017	0.00145	CcSEcCtD
Glycine—Hypotension—Diazepam—epilepsy syndrome	0.00017	0.00145	CcSEcCtD
Glycine—Tachycardia—Zonisamide—epilepsy syndrome	0.000168	0.00144	CcSEcCtD
Glycine—Diarrhoea—Clobazam—epilepsy syndrome	0.000168	0.00143	CcSEcCtD
Glycine—Pain—Levetiracetam—epilepsy syndrome	0.000167	0.00143	CcSEcCtD
Glycine—Vertigo—Lamotrigine—epilepsy syndrome	0.000167	0.00143	CcSEcCtD
Glycine—Dizziness—Lacosamide—epilepsy syndrome	0.000167	0.00143	CcSEcCtD
Glycine—Convulsion—Carbamazepine—epilepsy syndrome	0.000167	0.00143	CcSEcCtD
Glycine—Oedema—Clonazepam—epilepsy syndrome	0.000166	0.00142	CcSEcCtD
Glycine—Hypotension—Felbamate—epilepsy syndrome	0.000164	0.0014	CcSEcCtD
Glycine—Visual impairment—Valproic Acid—epilepsy syndrome	0.000164	0.0014	CcSEcCtD
Glycine—GRIN2A—brain—epilepsy syndrome	0.000163	0.00192	CbGeAlD
Glycine—Urinary retention—Topiramate—epilepsy syndrome	0.000163	0.00139	CcSEcCtD
Glycine—Nausea—Phenobarbital—epilepsy syndrome	0.000163	0.00139	CcSEcCtD
Glycine—Dizziness—Clobazam—epilepsy syndrome	0.000162	0.00139	CcSEcCtD
Glycine—SLC36A1—brain—epilepsy syndrome	0.000162	0.00191	CbGeAlD
Glycine—Tachycardia—Clonazepam—epilepsy syndrome	0.000162	0.00138	CcSEcCtD
Glycine—Convulsion—Lamotrigine—epilepsy syndrome	0.000161	0.00138	CcSEcCtD
Glycine—Urticaria—Propofol—epilepsy syndrome	0.000161	0.00138	CcSEcCtD
Glycine—Hypotension—Zonisamide—epilepsy syndrome	0.000161	0.00137	CcSEcCtD
Glycine—Tachycardia—Phenytoin—epilepsy syndrome	0.000161	0.00137	CcSEcCtD
Glycine—Vomiting—Lacosamide—epilepsy syndrome	0.00016	0.00137	CcSEcCtD
Glycine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.00016	0.00137	CcSEcCtD
Glycine—Nausea—Rufinamide—epilepsy syndrome	0.00016	0.00137	CcSEcCtD
Glycine—Dehydration—Topiramate—epilepsy syndrome	0.000159	0.00136	CcSEcCtD
Glycine—Pain—Vigabatrin—epilepsy syndrome	0.000158	0.00135	CcSEcCtD
Glycine—Urticaria—Midazolam—epilepsy syndrome	0.000158	0.00135	CcSEcCtD
Glycine—Oedema—Carbamazepine—epilepsy syndrome	0.000157	0.00134	CcSEcCtD
Glycine—Vomiting—Clobazam—epilepsy syndrome	0.000156	0.00133	CcSEcCtD
Glycine—Pain—Diazepam—epilepsy syndrome	0.000155	0.00133	CcSEcCtD
Glycine—Hypotension—Clonazepam—epilepsy syndrome	0.000155	0.00132	CcSEcCtD
Glycine—Rhinitis—Pregabalin—epilepsy syndrome	0.000154	0.00132	CcSEcCtD
Glycine—Hypotension—Phenytoin—epilepsy syndrome	0.000154	0.00132	CcSEcCtD
Glycine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000153	0.00131	CcSEcCtD
Glycine—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000153	0.00131	CcSEcCtD
Glycine—Chills—Valproic Acid—epilepsy syndrome	0.000152	0.0013	CcSEcCtD
Glycine—Oedema—Lamotrigine—epilepsy syndrome	0.000152	0.0013	CcSEcCtD
Glycine—Urticaria—Fosphenytoin—epilepsy syndrome	0.00015	0.00129	CcSEcCtD
Glycine—Pain—Felbamate—epilepsy syndrome	0.00015	0.00129	CcSEcCtD
Glycine—Nausea—Lacosamide—epilepsy syndrome	0.00015	0.00128	CcSEcCtD
Glycine—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000149	0.00128	CcSEcCtD
Glycine—Tachycardia—Lamotrigine—epilepsy syndrome	0.000148	0.00127	CcSEcCtD
Glycine—Visual impairment—Pregabalin—epilepsy syndrome	0.000148	0.00127	CcSEcCtD
Glycine—Hypotension—Carbamazepine—epilepsy syndrome	0.000147	0.00126	CcSEcCtD
Glycine—Urticaria—Vigabatrin—epilepsy syndrome	0.000146	0.00125	CcSEcCtD
Glycine—Hypersensitivity—Midazolam—epilepsy syndrome	0.000146	0.00125	CcSEcCtD
Glycine—Nausea—Clobazam—epilepsy syndrome	0.000145	0.00125	CcSEcCtD
Glycine—Dizziness—Acetazolamide—epilepsy syndrome	0.000144	0.00124	CcSEcCtD
Glycine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000144	0.00124	CcSEcCtD
Glycine—Urticaria—Diazepam—epilepsy syndrome	0.000144	0.00123	CcSEcCtD
Glycine—Angina pectoris—Topiramate—epilepsy syndrome	0.000144	0.00123	CcSEcCtD
Glycine—Back pain—Valproic Acid—epilepsy syndrome	0.000143	0.00122	CcSEcCtD
Glycine—GSS—brain—epilepsy syndrome	0.000142	0.00168	CbGeAlD
Glycine—Pain—Clonazepam—epilepsy syndrome	0.000142	0.00121	CcSEcCtD
Glycine—Rhinitis—Gabapentin—epilepsy syndrome	0.000141	0.00121	CcSEcCtD
Glycine—Pain—Oxcarbazepine—epilepsy syndrome	0.00014	0.0012	CcSEcCtD
Glycine—Urticaria—Felbamate—epilepsy syndrome	0.000139	0.00119	CcSEcCtD
Glycine—Vision blurred—Valproic Acid—epilepsy syndrome	0.000139	0.00119	CcSEcCtD
Glycine—Vomiting—Acetazolamide—epilepsy syndrome	0.000139	0.00119	CcSEcCtD
Glycine—Diarrhoea—Propofol—epilepsy syndrome	0.000139	0.00119	CcSEcCtD
Glycine—Chills—Pregabalin—epilepsy syndrome	0.000138	0.00118	CcSEcCtD
Glycine—Urticaria—Zonisamide—epilepsy syndrome	0.000137	0.00117	CcSEcCtD
Glycine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000136	0.00116	CcSEcCtD
Glycine—Visual impairment—Gabapentin—epilepsy syndrome	0.000136	0.00116	CcSEcCtD
Glycine—Pain—Carbamazepine—epilepsy syndrome	0.000134	0.00115	CcSEcCtD
Glycine—Dizziness—Propofol—epilepsy syndrome	0.000134	0.00115	CcSEcCtD
Glycine—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000134	0.00115	CcSEcCtD
Glycine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000134	0.00114	CcSEcCtD
Glycine—Vertigo—Valproic Acid—epilepsy syndrome	0.000133	0.00114	CcSEcCtD
Glycine—Urticaria—Clonazepam—epilepsy syndrome	0.000132	0.00113	CcSEcCtD
Glycine—Dizziness—Midazolam—epilepsy syndrome	0.000131	0.00112	CcSEcCtD
Glycine—Urticaria—Phenytoin—epilepsy syndrome	0.000131	0.00112	CcSEcCtD
Glycine—Urticaria—Oxcarbazepine—epilepsy syndrome	0.00013	0.00111	CcSEcCtD
Glycine—Pain—Lamotrigine—epilepsy syndrome	0.00013	0.00111	CcSEcCtD
Glycine—Nausea—Acetazolamide—epilepsy syndrome	0.00013	0.00111	CcSEcCtD
Glycine—Dizziness—Levetiracetam—epilepsy syndrome	0.00013	0.00111	CcSEcCtD
Glycine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000129	0.00111	CcSEcCtD
Glycine—Back pain—Pregabalin—epilepsy syndrome	0.000129	0.00111	CcSEcCtD
Glycine—Vomiting—Propofol—epilepsy syndrome	0.000129	0.0011	CcSEcCtD
Glycine—SLC16A10—cerebellum—epilepsy syndrome	0.000128	0.00152	CbGeAlD
Glycine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000127	0.00108	CcSEcCtD
Glycine—Chills—Gabapentin—epilepsy syndrome	0.000126	0.00108	CcSEcCtD
Glycine—Vomiting—Midazolam—epilepsy syndrome	0.000126	0.00108	CcSEcCtD
Glycine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000126	0.00108	CcSEcCtD
Glycine—Vision blurred—Pregabalin—epilepsy syndrome	0.000126	0.00108	CcSEcCtD
Glycine—Dizziness—Fosphenytoin—epilepsy syndrome	0.000125	0.00107	CcSEcCtD
Glycine—Urticaria—Carbamazepine—epilepsy syndrome	0.000125	0.00107	CcSEcCtD
Glycine—Vomiting—Levetiracetam—epilepsy syndrome	0.000125	0.00107	CcSEcCtD
Glycine—Diarrhoea—Diazepam—epilepsy syndrome	0.000124	0.00106	CcSEcCtD
Glycine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000122	0.00104	CcSEcCtD
Glycine—Dizziness—Vigabatrin—epilepsy syndrome	0.000122	0.00104	CcSEcCtD
Glycine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000121	0.00104	CcSEcCtD
Glycine—Oedema—Valproic Acid—epilepsy syndrome	0.000121	0.00103	CcSEcCtD
Glycine—Urticaria—Lamotrigine—epilepsy syndrome	0.000121	0.00103	CcSEcCtD
Glycine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000121	0.00103	CcSEcCtD
Glycine—Nausea—Propofol—epilepsy syndrome	0.00012	0.00103	CcSEcCtD
Glycine—Vomiting—Fosphenytoin—epilepsy syndrome	0.00012	0.00103	CcSEcCtD
Glycine—Diarrhoea—Felbamate—epilepsy syndrome	0.00012	0.00103	CcSEcCtD
Glycine—Vertigo—Pregabalin—epilepsy syndrome	0.00012	0.00103	CcSEcCtD
Glycine—Dizziness—Diazepam—epilepsy syndrome	0.00012	0.00103	CcSEcCtD
Glycine—Rhinitis—Topiramate—epilepsy syndrome	0.000119	0.00102	CcSEcCtD
Glycine—Back pain—Gabapentin—epilepsy syndrome	0.000119	0.00101	CcSEcCtD
Glycine—Nausea—Midazolam—epilepsy syndrome	0.000118	0.00101	CcSEcCtD
Glycine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000118	0.00101	CcSEcCtD
Glycine—Diarrhoea—Zonisamide—epilepsy syndrome	0.000118	0.00101	CcSEcCtD
Glycine—Vomiting—Vigabatrin—epilepsy syndrome	0.000117	0.001	CcSEcCtD
Glycine—Nausea—Levetiracetam—epilepsy syndrome	0.000116	0.000996	CcSEcCtD
Glycine—Dizziness—Felbamate—epilepsy syndrome	0.000116	0.000994	CcSEcCtD
Glycine—Convulsion—Pregabalin—epilepsy syndrome	0.000116	0.000991	CcSEcCtD
Glycine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000116	0.00099	CcSEcCtD
Glycine—Vision blurred—Gabapentin—epilepsy syndrome	0.000115	0.000988	CcSEcCtD
Glycine—Vomiting—Diazepam—epilepsy syndrome	0.000115	0.000987	CcSEcCtD
Glycine—Visual impairment—Topiramate—epilepsy syndrome	0.000114	0.000977	CcSEcCtD
Glycine—Dizziness—Zonisamide—epilepsy syndrome	0.000114	0.000973	CcSEcCtD
Glycine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000113	0.00097	CcSEcCtD
Glycine—Hypotension—Valproic Acid—epilepsy syndrome	0.000113	0.000965	CcSEcCtD
Glycine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000113	0.000964	CcSEcCtD
Glycine—Nausea—Fosphenytoin—epilepsy syndrome	0.000112	0.000961	CcSEcCtD
Glycine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000112	0.000958	CcSEcCtD
Glycine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000112	0.000957	CcSEcCtD
Glycine—Vomiting—Felbamate—epilepsy syndrome	0.000112	0.000956	CcSEcCtD
Glycine—Vertigo—Gabapentin—epilepsy syndrome	0.00011	0.000942	CcSEcCtD
Glycine—Dizziness—Clonazepam—epilepsy syndrome	0.00011	0.000938	CcSEcCtD
Glycine—Nausea—Vigabatrin—epilepsy syndrome	0.000109	0.000937	CcSEcCtD
Glycine—Vomiting—Zonisamide—epilepsy syndrome	0.000109	0.000935	CcSEcCtD
Glycine—Oedema—Pregabalin—epilepsy syndrome	0.000109	0.000933	CcSEcCtD
Glycine—Dizziness—Phenytoin—epilepsy syndrome	0.000109	0.000931	CcSEcCtD
Glycine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000108	0.000926	CcSEcCtD
Glycine—Nausea—Diazepam—epilepsy syndrome	0.000108	0.000922	CcSEcCtD
Glycine—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000107	0.00092	CcSEcCtD
Glycine—Tachycardia—Pregabalin—epilepsy syndrome	0.000106	0.000911	CcSEcCtD
Glycine—Chills—Topiramate—epilepsy syndrome	0.000106	0.000909	CcSEcCtD
Glycine—Convulsion—Gabapentin—epilepsy syndrome	0.000106	0.000909	CcSEcCtD
Glycine—Vomiting—Clonazepam—epilepsy syndrome	0.000105	0.000901	CcSEcCtD
Glycine—Vomiting—Phenytoin—epilepsy syndrome	0.000105	0.000895	CcSEcCtD
Glycine—Nausea—Felbamate—epilepsy syndrome	0.000104	0.000893	CcSEcCtD
Glycine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000104	0.000891	CcSEcCtD
Glycine—Dizziness—Carbamazepine—epilepsy syndrome	0.000104	0.000889	CcSEcCtD
Glycine—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000104	0.000889	CcSEcCtD
Glycine—Pain—Valproic Acid—epilepsy syndrome	0.000103	0.000883	CcSEcCtD
Glycine—Nausea—Zonisamide—epilepsy syndrome	0.000102	0.000874	CcSEcCtD
Glycine—Hypotension—Pregabalin—epilepsy syndrome	0.000102	0.000872	CcSEcCtD
Glycine—Dizziness—Lamotrigine—epilepsy syndrome	0.0001	0.000859	CcSEcCtD
Glycine—Oedema—Gabapentin—epilepsy syndrome	0.0001	0.000856	CcSEcCtD
Glycine—Vomiting—Carbamazepine—epilepsy syndrome	9.99e-05	0.000855	CcSEcCtD
Glycine—Back pain—Topiramate—epilepsy syndrome	9.97e-05	0.000853	CcSEcCtD
Glycine—Nausea—Clonazepam—epilepsy syndrome	9.84e-05	0.000842	CcSEcCtD
Glycine—Nausea—Phenytoin—epilepsy syndrome	9.77e-05	0.000837	CcSEcCtD
Glycine—Tachycardia—Gabapentin—epilepsy syndrome	9.76e-05	0.000835	CcSEcCtD
Glycine—Nausea—Oxcarbazepine—epilepsy syndrome	9.72e-05	0.000832	CcSEcCtD
Glycine—Vision blurred—Topiramate—epilepsy syndrome	9.71e-05	0.000831	CcSEcCtD
Glycine—Vomiting—Lamotrigine—epilepsy syndrome	9.65e-05	0.000826	CcSEcCtD
Glycine—Urticaria—Valproic Acid—epilepsy syndrome	9.58e-05	0.00082	CcSEcCtD
Glycine—Hypotension—Gabapentin—epilepsy syndrome	9.34e-05	0.0008	CcSEcCtD
Glycine—Nausea—Carbamazepine—epilepsy syndrome	9.33e-05	0.000798	CcSEcCtD
Glycine—Pain—Pregabalin—epilepsy syndrome	9.32e-05	0.000798	CcSEcCtD
Glycine—Vertigo—Topiramate—epilepsy syndrome	9.26e-05	0.000793	CcSEcCtD
Glycine—Nausea—Lamotrigine—epilepsy syndrome	9.02e-05	0.000772	CcSEcCtD
Glycine—Convulsion—Topiramate—epilepsy syndrome	8.93e-05	0.000764	CcSEcCtD
Glycine—Hypersensitivity—Valproic Acid—epilepsy syndrome	8.89e-05	0.000761	CcSEcCtD
Glycine—Urticaria—Pregabalin—epilepsy syndrome	8.66e-05	0.000741	CcSEcCtD
Glycine—Pain—Gabapentin—epilepsy syndrome	8.55e-05	0.000732	CcSEcCtD
Glycine—Oedema—Topiramate—epilepsy syndrome	8.41e-05	0.00072	CcSEcCtD
Glycine—Diarrhoea—Valproic Acid—epilepsy syndrome	8.25e-05	0.000706	CcSEcCtD
Glycine—Tachycardia—Topiramate—epilepsy syndrome	8.21e-05	0.000703	CcSEcCtD
Glycine—Hypersensitivity—Pregabalin—epilepsy syndrome	8.03e-05	0.000688	CcSEcCtD
Glycine—Dizziness—Valproic Acid—epilepsy syndrome	7.98e-05	0.000683	CcSEcCtD
Glycine—Urticaria—Gabapentin—epilepsy syndrome	7.94e-05	0.00068	CcSEcCtD
Glycine—Hypotension—Topiramate—epilepsy syndrome	7.86e-05	0.000673	CcSEcCtD
Glycine—Vomiting—Valproic Acid—epilepsy syndrome	7.67e-05	0.000656	CcSEcCtD
Glycine—Diarrhoea—Pregabalin—epilepsy syndrome	7.46e-05	0.000639	CcSEcCtD
Glycine—Hypersensitivity—Gabapentin—epilepsy syndrome	7.37e-05	0.000631	CcSEcCtD
Glycine—Dizziness—Pregabalin—epilepsy syndrome	7.21e-05	0.000617	CcSEcCtD
Glycine—Pain—Topiramate—epilepsy syndrome	7.19e-05	0.000616	CcSEcCtD
Glycine—Nausea—Valproic Acid—epilepsy syndrome	7.16e-05	0.000613	CcSEcCtD
Glycine—Vomiting—Pregabalin—epilepsy syndrome	6.93e-05	0.000593	CcSEcCtD
Glycine—Diarrhoea—Gabapentin—epilepsy syndrome	6.84e-05	0.000586	CcSEcCtD
Glycine—Urticaria—Topiramate—epilepsy syndrome	6.68e-05	0.000572	CcSEcCtD
Glycine—Dizziness—Gabapentin—epilepsy syndrome	6.61e-05	0.000566	CcSEcCtD
Glycine—Nausea—Pregabalin—epilepsy syndrome	6.48e-05	0.000554	CcSEcCtD
Glycine—Vomiting—Gabapentin—epilepsy syndrome	6.36e-05	0.000544	CcSEcCtD
Glycine—Hypersensitivity—Topiramate—epilepsy syndrome	6.2e-05	0.00053	CcSEcCtD
Glycine—Nausea—Gabapentin—epilepsy syndrome	5.94e-05	0.000508	CcSEcCtD
Glycine—Diarrhoea—Topiramate—epilepsy syndrome	5.76e-05	0.000493	CcSEcCtD
Glycine—Dizziness—Topiramate—epilepsy syndrome	5.56e-05	0.000476	CcSEcCtD
Glycine—Vomiting—Topiramate—epilepsy syndrome	5.35e-05	0.000458	CcSEcCtD
Glycine—Nausea—Topiramate—epilepsy syndrome	5e-05	0.000428	CcSEcCtD
Glycine—SLC36A1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	9.46e-06	6.25e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HTR2A—epilepsy syndrome	9.44e-06	6.24e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—SLC2A1—epilepsy syndrome	9.38e-06	6.2e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	9.37e-06	6.19e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PPIA—epilepsy syndrome	9.34e-06	6.17e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PLCB1—epilepsy syndrome	9.28e-06	6.13e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CYP2D6—epilepsy syndrome	9.24e-06	6.11e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—TH—epilepsy syndrome	9.24e-06	6.11e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PRKCB—epilepsy syndrome	9.11e-06	6.02e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.1e-06	6.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TSC1—epilepsy syndrome	9.09e-06	6e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTK2B—epilepsy syndrome	9.09e-06	6e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	9.08e-06	6e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—KCNJ11—epilepsy syndrome	8.99e-06	5.94e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CHRM3—epilepsy syndrome	8.99e-06	5.94e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCG2—epilepsy syndrome	8.99e-06	5.94e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	8.98e-06	5.93e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AGT—epilepsy syndrome	8.96e-06	5.92e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CYP2D6—epilepsy syndrome	8.95e-06	5.91e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	8.84e-06	5.84e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR2—epilepsy syndrome	8.84e-06	5.84e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SST—epilepsy syndrome	8.84e-06	5.84e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NTRK2—epilepsy syndrome	8.84e-06	5.84e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ADRA2A—epilepsy syndrome	8.8e-06	5.81e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DUSP6—epilepsy syndrome	8.76e-06	5.79e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—KCNJ11—epilepsy syndrome	8.76e-06	5.79e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP2C19—epilepsy syndrome	8.76e-06	5.79e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CHRM3—epilepsy syndrome	8.76e-06	5.79e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—BCHE—epilepsy syndrome	8.76e-06	5.79e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP11A1—epilepsy syndrome	8.71e-06	5.75e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ADRA2A—epilepsy syndrome	8.65e-06	5.72e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	8.62e-06	5.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PLAT—epilepsy syndrome	8.62e-06	5.69e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ADRA2A—epilepsy syndrome	8.52e-06	5.63e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—BCHE—epilepsy syndrome	8.49e-06	5.61e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—SLC2A1—epilepsy syndrome	8.36e-06	5.52e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AGT—epilepsy syndrome	8.35e-06	5.52e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BDKRB2—epilepsy syndrome	8.31e-06	5.49e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL12—epilepsy syndrome	8.31e-06	5.49e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—POMC—epilepsy syndrome	8.3e-06	5.48e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PRKCB—epilepsy syndrome	8.27e-06	5.47e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PLCB1—epilepsy syndrome	8.27e-06	5.46e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6ST—epilepsy syndrome	8.24e-06	5.44e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—TH—epilepsy syndrome	8.24e-06	5.44e-05	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—PRKCB—epilepsy syndrome	8.2e-06	5.42e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—APOE—epilepsy syndrome	8.18e-06	5.4e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JUNB—epilepsy syndrome	8.16e-06	5.39e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CNR1—epilepsy syndrome	8.16e-06	5.39e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PLCB1—epilepsy syndrome	8.13e-06	5.37e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—SLC2A1—epilepsy syndrome	8.1e-06	5.35e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—HMOX1—epilepsy syndrome	8.09e-06	5.34e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—HMOX1—epilepsy syndrome	8.09e-06	5.34e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—HMOX1—epilepsy syndrome	8.09e-06	5.34e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—HMOX1—epilepsy syndrome	8.09e-06	5.34e-05	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.06e-06	5.33e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PLCB1—epilepsy syndrome	8.01e-06	5.29e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CAT—epilepsy syndrome	7.98e-06	5.27e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CAT—epilepsy syndrome	7.98e-06	5.27e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CAT—epilepsy syndrome	7.98e-06	5.27e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—TH—epilepsy syndrome	7.98e-06	5.27e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—CAT—epilepsy syndrome	7.98e-06	5.27e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HTR7—epilepsy syndrome	7.96e-06	5.26e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CYP2D6—epilepsy syndrome	7.86e-06	5.19e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	7.85e-06	5.19e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—ABCB1—epilepsy syndrome	7.76e-06	5.13e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ABCB1—epilepsy syndrome	7.76e-06	5.13e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ABCB1—epilepsy syndrome	7.76e-06	5.13e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ABCB1—epilepsy syndrome	7.76e-06	5.13e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HBEGF—epilepsy syndrome	7.73e-06	5.11e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—HMOX1—epilepsy syndrome	7.71e-06	5.1e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—CAT—epilepsy syndrome	7.61e-06	5.03e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT3—epilepsy syndrome	7.59e-06	5.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—POMC—epilepsy syndrome	7.54e-06	4.98e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ADRA2A—epilepsy syndrome	7.48e-06	4.94e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—BCHE—epilepsy syndrome	7.45e-06	4.92e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ADAM10—epilepsy syndrome	7.41e-06	4.9e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—ABCB1—epilepsy syndrome	7.4e-06	4.89e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCL2—epilepsy syndrome	7.38e-06	4.87e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCG2—epilepsy syndrome	7.33e-06	4.84e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	7.33e-06	4.84e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GPX1—epilepsy syndrome	7.22e-06	4.77e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GPX1—epilepsy syndrome	7.22e-06	4.77e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—GPX1—epilepsy syndrome	7.22e-06	4.77e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GPX1—epilepsy syndrome	7.22e-06	4.77e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP2C19—epilepsy syndrome	7.14e-06	4.72e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCG2—epilepsy syndrome	7.14e-06	4.72e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—SLC2A1—epilepsy syndrome	7.11e-06	4.7e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP11A1—epilepsy syndrome	7.1e-06	4.69e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PLCB1—epilepsy syndrome	7.03e-06	4.64e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—POMC—epilepsy syndrome	7.03e-06	4.64e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—S100B—epilepsy syndrome	7.01e-06	4.63e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—TH—epilepsy syndrome	7e-06	4.63e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	6.99e-06	4.62e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP2C19—epilepsy syndrome	6.96e-06	4.6e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SOCS3—epilepsy syndrome	6.94e-06	4.58e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDC42—epilepsy syndrome	6.92e-06	4.57e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SLC2A1—epilepsy syndrome	6.92e-06	4.57e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP11A1—epilepsy syndrome	6.92e-06	4.57e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—GPX1—epilepsy syndrome	6.88e-06	4.55e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—HMOX1—epilepsy syndrome	6.88e-06	4.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—JUNB—epilepsy syndrome	6.87e-06	4.54e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS1—epilepsy syndrome	6.82e-06	4.5e-05	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	6.79e-06	4.49e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CAT—epilepsy syndrome	6.78e-06	4.48e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AVP—epilepsy syndrome	6.7e-06	4.43e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—HMOX1—epilepsy syndrome	6.66e-06	4.4e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ABCB1—epilepsy syndrome	6.6e-06	4.36e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CAT—epilepsy syndrome	6.57e-06	4.34e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HBEGF—epilepsy syndrome	6.5e-06	4.3e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP2D6—epilepsy syndrome	6.41e-06	4.23e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ALB—epilepsy syndrome	6.41e-06	4.23e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ABCB1—epilepsy syndrome	6.39e-06	4.22e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT3—epilepsy syndrome	6.38e-06	4.22e-05	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.37e-06	4.21e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HES1—epilepsy syndrome	6.34e-06	4.19e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AGT—epilepsy syndrome	6.33e-06	4.18e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AGT—epilepsy syndrome	6.33e-06	4.18e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AGT—epilepsy syndrome	6.33e-06	4.18e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AGT—epilepsy syndrome	6.33e-06	4.18e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP2D6—epilepsy syndrome	6.24e-06	4.12e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ADAM10—epilepsy syndrome	6.24e-06	4.12e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—APOE—epilepsy syndrome	6.2e-06	4.1e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—APOE—epilepsy syndrome	6.2e-06	4.1e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—APOE—epilepsy syndrome	6.2e-06	4.1e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—APOE—epilepsy syndrome	6.2e-06	4.1e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FYN—epilepsy syndrome	6.16e-06	4.07e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—H2AFX—epilepsy syndrome	6.14e-06	4.06e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—GPX1—epilepsy syndrome	6.13e-06	4.05e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MEF2C—epilepsy syndrome	6.13e-06	4.05e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ADRA2A—epilepsy syndrome	6.1e-06	4.03e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—BCHE—epilepsy syndrome	6.07e-06	4.01e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AGT—epilepsy syndrome	6.04e-06	3.99e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ADRA2A—epilepsy syndrome	5.94e-06	3.93e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GPX1—epilepsy syndrome	5.94e-06	3.93e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—YWHAZ—epilepsy syndrome	5.92e-06	3.91e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—BCHE—epilepsy syndrome	5.92e-06	3.91e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—APOE—epilepsy syndrome	5.91e-06	3.91e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NGF—epilepsy syndrome	5.86e-06	3.87e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—HMOX1—epilepsy syndrome	5.85e-06	3.86e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDC42—epilepsy syndrome	5.83e-06	3.85e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—SLC2A1—epilepsy syndrome	5.79e-06	3.83e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CAT—epilepsy syndrome	5.77e-06	3.81e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	5.75e-06	3.8e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PLCB1—epilepsy syndrome	5.73e-06	3.79e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TH—epilepsy syndrome	5.71e-06	3.77e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—AVP—epilepsy syndrome	5.7e-06	3.76e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR5—epilepsy syndrome	5.7e-06	3.76e-05	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.68e-06	3.75e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC2A1—epilepsy syndrome	5.65e-06	3.73e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ABCB1—epilepsy syndrome	5.61e-06	3.71e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—epilepsy syndrome	5.6e-06	3.7e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PLCB1—epilepsy syndrome	5.58e-06	3.69e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HTR2A—epilepsy syndrome	5.58e-06	3.68e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—TH—epilepsy syndrome	5.56e-06	3.68e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	5.52e-06	3.65e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AGT—epilepsy syndrome	5.38e-06	3.55e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HES1—epilepsy syndrome	5.33e-06	3.52e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—POMC—epilepsy syndrome	5.33e-06	3.52e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—POMC—epilepsy syndrome	5.33e-06	3.52e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—POMC—epilepsy syndrome	5.33e-06	3.52e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—POMC—epilepsy syndrome	5.33e-06	3.52e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TSC2—epilepsy syndrome	5.3e-06	3.5e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AGT—epilepsy syndrome	5.29e-06	3.5e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOE—epilepsy syndrome	5.27e-06	3.48e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GPX1—epilepsy syndrome	5.22e-06	3.45e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AGT—epilepsy syndrome	5.21e-06	3.44e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FYN—epilepsy syndrome	5.19e-06	3.43e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOE—epilepsy syndrome	5.18e-06	3.42e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—H2AFX—epilepsy syndrome	5.17e-06	3.41e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOE—epilepsy syndrome	5.1e-06	3.37e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—POMC—epilepsy syndrome	5.08e-06	3.36e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KDR—epilepsy syndrome	5.08e-06	3.35e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—YWHAZ—epilepsy syndrome	4.99e-06	3.29e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PRKCB—epilepsy syndrome	4.89e-06	3.23e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6ST—epilepsy syndrome	4.87e-06	3.22e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—epilepsy syndrome	4.86e-06	3.21e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—epilepsy syndrome	4.86e-06	3.21e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—epilepsy syndrome	4.86e-06	3.21e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—epilepsy syndrome	4.86e-06	3.21e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CCR5—epilepsy syndrome	4.8e-06	3.17e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HMOX1—epilepsy syndrome	4.77e-06	3.15e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CAT—epilepsy syndrome	4.7e-06	3.11e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HMOX1—epilepsy syndrome	4.64e-06	3.07e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—epilepsy syndrome	4.63e-06	3.06e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CAT—epilepsy syndrome	4.58e-06	3.03e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AGT—epilepsy syndrome	4.57e-06	3.02e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ABCB1—epilepsy syndrome	4.57e-06	3.02e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—POMC—epilepsy syndrome	4.53e-06	2.99e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOE—epilepsy syndrome	4.48e-06	2.96e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TSC2—epilepsy syndrome	4.46e-06	2.95e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ABCB1—epilepsy syndrome	4.46e-06	2.94e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—POMC—epilepsy syndrome	4.45e-06	2.94e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—POMC—epilepsy syndrome	4.39e-06	2.9e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOE—epilepsy syndrome	4.36e-06	2.88e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL2—epilepsy syndrome	4.36e-06	2.88e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GPX1—epilepsy syndrome	4.25e-06	2.81e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—epilepsy syndrome	4.25e-06	2.81e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—epilepsy syndrome	4.25e-06	2.81e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—epilepsy syndrome	4.25e-06	2.81e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—epilepsy syndrome	4.25e-06	2.81e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GPX1—epilepsy syndrome	4.14e-06	2.74e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—epilepsy syndrome	4.13e-06	2.73e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6ST—epilepsy syndrome	4.1e-06	2.71e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS2—epilepsy syndrome	4.07e-06	2.69e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—epilepsy syndrome	4.05e-06	2.68e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—epilepsy syndrome	4e-06	2.64e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGF2—epilepsy syndrome	3.94e-06	2.6e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—POMC—epilepsy syndrome	3.85e-06	2.54e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AGT—epilepsy syndrome	3.73e-06	2.46e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RELA—epilepsy syndrome	3.66e-06	2.41e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOE—epilepsy syndrome	3.65e-06	2.41e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AGT—epilepsy syndrome	3.63e-06	2.4e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—epilepsy syndrome	3.62e-06	2.39e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—epilepsy syndrome	3.61e-06	2.39e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MTOR—epilepsy syndrome	3.58e-06	2.37e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOE—epilepsy syndrome	3.56e-06	2.35e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—epilepsy syndrome	3.51e-06	2.32e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—epilepsy syndrome	3.5e-06	2.31e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.45e-06	2.28e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—epilepsy syndrome	3.33e-06	2.2e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FGF2—epilepsy syndrome	3.31e-06	2.19e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CASP3—epilepsy syndrome	3.3e-06	2.18e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JUN—epilepsy syndrome	3.2e-06	2.12e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—POMC—epilepsy syndrome	3.14e-06	2.07e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—epilepsy syndrome	3.12e-06	2.06e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—epilepsy syndrome	3.07e-06	2.03e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—POMC—epilepsy syndrome	3.06e-06	2.02e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—epilepsy syndrome	3.02e-06	2e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTOR—epilepsy syndrome	3.02e-06	1.99e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—epilepsy syndrome	2.99e-06	1.97e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—epilepsy syndrome	2.87e-06	1.9e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—epilepsy syndrome	2.86e-06	1.89e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—epilepsy syndrome	2.82e-06	1.86e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—VEGFA—epilepsy syndrome	2.8e-06	1.85e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—epilepsy syndrome	2.79e-06	1.84e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—epilepsy syndrome	2.5e-06	1.65e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—epilepsy syndrome	2.44e-06	1.61e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—epilepsy syndrome	2.42e-06	1.6e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—epilepsy syndrome	2.13e-06	1.41e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—epilepsy syndrome	2.13e-06	1.41e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—epilepsy syndrome	2.13e-06	1.41e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—epilepsy syndrome	2.13e-06	1.41e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—epilepsy syndrome	2.04e-06	1.35e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—epilepsy syndrome	1.82e-06	1.2e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—epilepsy syndrome	1.79e-06	1.18e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—epilepsy syndrome	1.76e-06	1.16e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—epilepsy syndrome	1.54e-06	1.02e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—epilepsy syndrome	1.5e-06	9.93e-06	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—epilepsy syndrome	1.26e-06	8.31e-06	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—epilepsy syndrome	1.23e-06	8.1e-06	CbGpPWpGaD
